newsfilter
← Latest News
Business Wire·

Gamida Cell Provides Regulatory Update on Omidubicel

Recent company submission in response to FDA request extends PDUFA date by three months Gamida Cell Ltd. (NASDAQ:GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematological and